Loading…
Access to Pediatric Technologies Act of 2024
Legislative Progress
Introduced
September 25, 2024
Latest Action
September 25, 2024
Primary Sponsor
Marsha BlackburnRepublican(TN)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · fourth_quarter · Medicare/Medicaid
Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. Issues related to reporting of Average Sales Price for skin substitutes. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices. S. 5275 / H.R. 9157, Access to Pediatric Technologies Act of 2024.
Client expense: Not reported · Firm income: $50,000
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Medicare/Medicaid
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Client expense: $430,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medicare/Medicaid
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Client expense: $430,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medicare/Medicaid
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE